Inovalon Holdings (INOV) Receiving Somewhat Favorable Press Coverage, Accern Reports
News headlines about Inovalon Holdings (NASDAQ:INOV) have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern scores the sentiment of press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Inovalon Holdings earned a media sentiment score of 0.17 on Accern’s scale. Accern also gave news stories about the technology company an impact score of 46.5619276045698 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
These are some of the media headlines that may have effected Accern’s analysis:
- Tableau Software, Inc. (DATA) and Inovalon Holdings (INOV) in Uptrend Stocks – Investing News Update (investingbizz.com)
- From A Very Different Angle: Inovalon Holdings, Inc. (INOV), Dynavax Technologies Corporation (DVAX) – AllStockNews (allstocknews.com)
- Inovalon Holdings, Inc. (NasdaqGS:INOV), Aerie Pharmaceuticals, Inc. (NasdaqGM:AERI): How Do These Stocks … – Evergreen Caller (evergreencaller.com)
- Inovalon Holdings, Inc. breached its 50 day moving average in a Bullish Manner : INOV-US : August 4, 2017 (finance.yahoo.com)
- Edited Transcript of INOV earnings conference call or presentation 2-Aug-17 9:00pm GMT (finance.yahoo.com)
INOV has been the subject of a number of recent research reports. Zacks Investment Research raised shares of Inovalon Holdings from a “hold” rating to a “buy” rating and set a $13.00 target price for the company in a report on Wednesday, April 26th. BidaskClub lowered shares of Inovalon Holdings from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 12th. Finally, Robert W. Baird reissued a “neutral” rating and issued a $12.00 target price (up from $11.00) on shares of Inovalon Holdings in a report on Friday, June 16th. Two analysts have rated the stock with a sell rating, four have given a hold rating and four have given a buy rating to the stock. Inovalon Holdings presently has an average rating of “Hold” and a consensus price target of $15.17.
Inovalon Holdings (NASDAQ:INOV) traded up 4.48% on Friday, hitting $14.00. 663,927 shares of the company were exchanged. Inovalon Holdings has a 52-week low of $8.60 and a 52-week high of $19.40. The stock has a market capitalization of $2.00 billion, a P/E ratio of 117.65 and a beta of 1.19. The stock’s 50-day moving average price is $13.04 and its 200-day moving average price is $12.48.
Inovalon Holdings (NASDAQ:INOV) last posted its quarterly earnings data on Wednesday, August 2nd. The technology company reported $0.08 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.07 by $0.01. Inovalon Holdings had a return on equity of 5.10% and a net margin of 4.13%. The firm had revenue of $110.60 million during the quarter, compared to the consensus estimate of $108.73 million. During the same period in the prior year, the company earned $0.14 EPS. The firm’s revenue was down 10.7% compared to the same quarter last year. On average, equities research analysts anticipate that Inovalon Holdings will post $0.30 earnings per share for the current fiscal year.
In other Inovalon Holdings news, insider Joseph R. Rostock sold 104,649 shares of the firm’s stock in a transaction on Monday, May 8th. The stock was sold at an average price of $13.07, for a total value of $1,367,762.43. Following the completion of the sale, the insider now directly owns 171,824 shares of the company’s stock, valued at approximately $2,245,739.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Shauna L. Vernal sold 19,332 shares of the firm’s stock in a transaction on Wednesday, May 24th. The stock was sold at an average price of $13.60, for a total value of $262,915.20. Following the completion of the sale, the insider now directly owns 66,261 shares of the company’s stock, valued at $901,149.60. The disclosure for this sale can be found here. 48.28% of the stock is owned by company insiders.
TRADEMARK VIOLATION WARNING: “Inovalon Holdings (INOV) Receiving Somewhat Favorable Press Coverage, Accern Reports” was published by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://www.dailypolitical.com/2017/08/06/inovalon-holdings-inov-receiving-somewhat-favorable-press-coverage-accern-reports.html.
About Inovalon Holdings
Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.
Receive News & Ratings for Inovalon Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.